BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1179 related articles for article (PubMed ID: 8904247)

  • 1. [Expression of nm23/NDP kinase and cancer metastasis].
    Okada K; Shiku H
    Nihon Rinsho; 1996 Mar; 54(3):845-53. PubMed ID: 8904247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nm23/NDP kinase and cancer metastasis].
    Kimura N
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):332-7. PubMed ID: 8382464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nucleoside diphosphate kinase/Nm23 and metastatic potency].
    Lacombe ML
    Bull Cancer; 1993 Aug; 80(8):717-22. PubMed ID: 8204954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
    Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
    Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nm23-H1: a metastasis-associated gene.
    Tee YT; Chen GD; Lin LY; Ko JL; Wang PH
    Taiwan J Obstet Gynecol; 2006 Jun; 45(2):107-13. PubMed ID: 17197349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
    Baba H; Urano T; Okada K; Furukawa K; Nakayama E; Tanaka H; Iwasaki K; Shiku H
    Cancer Res; 1995 May; 55(9):1977-81. PubMed ID: 7728768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nm23 and tumour metastasis: basic and translational advances.
    Freije JM; MacDonald NJ; Steeg PS
    Biochem Soc Symp; 1998; 63():261-71. PubMed ID: 9513729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study.
    Sawan A; Lascu I; Veron M; Anderson JJ; Wright C; Horne CH; Angus B
    J Pathol; 1994 Jan; 172(1):27-34. PubMed ID: 7931824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nm23--a metastasis suppressor gene?
    Royds JA; Rees RC; Stephenson TJ
    J Pathol; 1994 Jul; 173(3):211-2. PubMed ID: 7931840
    [No Abstract]   [Full Text] [Related]  

  • 11. [Expression and anti-metastatic potential of nm 23/NDP kinase in human head and neck cancer cells].
    Miyazaki H
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):189-95. PubMed ID: 9711037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of multifunctional protein, NDP kinase/nm 23].
    Kimura N; Shimada N; Fukuda M; Ishii A; Seto H; Yasutomo Y; Takagi Y; Ishikawa N
    Tanpakushitsu Kakusan Koso; 1997 Apr; 42(5):745-60. PubMed ID: 9095670
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
    Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Nm23-H1 gene expression and metastasis of ovarian carcinoma.
    Gao QL; Ma D; Meng L; Wang SX; Wang CY; Lu YP; Zhang AL; Li J
    Ai Zheng; 2004 Jun; 23(6):650-4. PubMed ID: 15191664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis.
    Luo W; Matsuo K; Nagayama Y; Urano T; Furukawa K; Takeshita A; Nakayama T; Yokoyama N; Yamashita S; Izumi M
    Thyroid; 1993; 3(2):105-9. PubMed ID: 8396479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of the promoter region of human nm23-H1, a metastasis suppressor gene.
    Chen HC; Wang L; Banerjee S
    Oncogene; 1994 Oct; 9(10):2905-12. PubMed ID: 8084595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
    Huijzer JC; McFarland M; Niles RM; Meadows GG
    J Cell Physiol; 1996 Mar; 166(3):487-94. PubMed ID: 8600152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.
    Giarnieri E; Alderisio M; Valli C; Vecchione A; Forte A; Turano R; Pulcini M
    Anticancer Res; 1995; 15(5B):2049-53. PubMed ID: 8572601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas.
    Borchers H; Meyers FJ; Gumerlock PH; Stewart SL; deVere White RW
    J Urol; 1996 Jun; 155(6):2080-4. PubMed ID: 8618340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.